4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CK Life Sciences Int'l., (Holdings) Inc. (0775) operates in the Biotechnology industry and is headquartered in Tai Po, Hong Kong with about 1,925 employees. Its market capitalization is roughly HK$5 billion. In the fiscal year ended 2025-12-31, 0775 reported HK$5.4B in revenue and (HK$187M) in net income.
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America.
Interactive charts & full statements → Open the 0775 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | HK$5.4B | HK$5.5B | HK$5.3B | HK$5.3B |
| Gross Profit | HK$1.6B | HK$1.7B | HK$1.6B | HK$1.6B |
| Operating Income (EBIT) | (HK$131M) | HK$78M | HK$224M | HK$242M |
| Net Income | (HK$187M) | (HK$127M) | HK$17M | HK$132M |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | (HK$77M) | (HK$96M) | (HK$96M) |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HK$11.8B | HK$10.8B | HK$11.2B | HK$11.3B | — |
| Total Liabilities | HK$8.0B | HK$7.3B | HK$7.1B | HK$7.1B | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0775 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms